D. Western Therapeutics Institute Balance Sheet Health
Financial Health criteria checks 5/6
D. Western Therapeutics Institute has a total shareholder equity of ¥958.0M and total debt of ¥993.0M, which brings its debt-to-equity ratio to 103.7%. Its total assets and total liabilities are ¥2.1B and ¥1.2B respectively.
Key information
103.7%
Debt to equity ratio
JP¥993.00m
Debt
Interest coverage ratio | n/a |
Cash | JP¥1.39b |
Equity | JP¥958.00m |
Total liabilities | JP¥1.16b |
Total assets | JP¥2.12b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6DW's short term assets (¥1.9B) exceed its short term liabilities (¥154.0M).
Long Term Liabilities: 6DW's short term assets (¥1.9B) exceed its long term liabilities (¥1.0B).
Debt to Equity History and Analysis
Debt Level: 6DW has more cash than its total debt.
Reducing Debt: 6DW's debt to equity ratio has increased from 39.5% to 103.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6DW has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6DW has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 4.5% each year.